Discussion Forums > Announcements
Singapore Scientific Programme Schedule
Andy Battaglia:
The schedule of events for the upcoming Singapore Conference can be viewed at
http://www.thalassaemia2008singapore.org/004ScientificProgramme.htm
If you have not yet registered, please do so soon. The schedule looks excellent and the conference will be well worth attending.
Text version with no columns: There are two simultaneous conferences.
1) 11th International Conference on Thalassaemia & Haemoglobinopathies (Symposiums)
2) 13th International TIF Conference for Thalassaemia Patients & Parents (Sessions)
Scientific Programme
Pre-Conference Workshop, 7 October 2008 (Tuesday)
Main Programme, Day 1, 8 October 2008 (Wednesday)
Main Programme, Day 2, 9 October 2008 (Thursday)
Main Programme, Day 3, 10 October 2008 (Friday)
Main Programme, Day 4, 11 October 2008 (Saturday)
Novartis Lunch Symposium, 8 October 2008 (Wednesday)
Novartis Dinner Symposium, 8 October 2008 (Wednesday)
Osato Lunch Symposium, 9 October 2008 (Thursday)
Pre-Conference Workshop, 7 October 2008 (Tuesday)
KK Women's and Children's Hospital
The Auditorium
Workshop 1 ( 0900 - 1200 )
Magnetic Resonance T2* Assessment of Iron Overload
Workshop 2 ( 1400 - 1700 )
Diagnosis of Thalassaemia - Laboratory Methods, Molecular Basis and Screening Strategy
TOP>
Main Programme, Day 1, 8 October 2008 (Wednesday)
Suntec Singapore International Convention & Exhibition Centre
Ballroom 1
Opening Ceremony ( 0815 - 0915 )
Plenary 1 ( 0915 - 1000 )
Thalassaemia As a Global Health Problem,
Sir David WEATHERALL, United Kingdom
Tea break at Exhibition Area (Concourse, Level 3) ( 1000 - 1045 )
Room 1
Room 2 Room 3
11th International Conference on Thalassaemia & Haemoglobinopathies
13th International TIF Conference for
Thalassaemia Patients & Parents
Free Paper Sessions
Symposium 1 ( 1045 - 1215 )
Molecular Therapeutics and Alternative Therapies for Thalassaemia
Chairpersons: Prof Eliezer RACHMILEWITZ, Israel /
Dr Michael ANTONIOU, United Kingdom
* Gene Therapy - Is It A Reality?
Dr Michael ANTONIOU, United Kingdom
* Molecular Therapies in Beta-Thalassaemia
Prof THEIN Swee Lay,
United Kingdom
* Oxidative Stress in Thalassaemia and
Haemoglobinopathies: Mechanism and Treatment
Prof Eliezer RACHMILEWITZ, Israel
Session 1 (1045 - 1215 )
Chairpersons: Prof Alan COHEN,United States of Amercia / Mrs Aggie MICHAEL, Singapore
What is Thalassaemia?
* Background - How / Why Do We Get Thal? How Does It Become Major? When Does Treatment Start?
Dr Paul TELFER, United Kingdom
* Prevention, Screening & Ethics
Dr Mary PETROU, United Kingdom
* Transplantations
Dr Phil DARBYSHIRE, United Kingdom
Blood Transfusions
* Why Do Patients Need Blood Transfusions, What Happens During Transfusions? What Do We Do When There's A
Reaction?
Dr Diana TEO, Singapore
Q & A
Free Papers 1
( 1045 - 1215 )
Novartis Lunch Symposium
(For Medical Professionals only)
( 1215 - 1345 ) Lunch Break
( 1215 - 1330 ) Lunch Break
( 1215 - 1330 )
Symposium 2 ( 1345 - 1515 )
Epidemiology
Chairpersons: Sir David WEATHERALL,
United Kingdom / Dr Vip VIPRAKASIT, Thailand
* Why Are The Haemoglobin Disorders So Common?
Sir David WEATHERALL, United Kingdom
* Global Distribution and Heterogeneity of the Alpha Thalassaemias
Dr Vip VIPRAKASIT, Thailand
* Epidemiology of the Beta Thalassaemias
Dr Roshan COLAH, India
Session 2 ( 1330 - 1500 )
Chairpersons: Dr TAN Ru-San, Singapore /
Ms Gargi PAHUJA, United States of America
Blood Donation
* How to Encourage Voluntary Blood Donation?
Myths & Beliefs of Blood Giving
Speaker to be confirmed
* Blood Transfusion and What It Means to
Thalassaemics?
Mr George CONSTANTINOU, United Kingdom
Heart & Its Problems
* Cardiac Problems & Solutions
Dr Malcolm WALKER, United Kingdom
* Cardiac Problems & How Do We Deal with It in Asia (Before & After MRI T2*)?
Dr DAN Giap Liang, Malaysia
Q & A
Free Papers 2
( 1330 - 1500 )
Tea break at Exhibition Area (Concourse, Level 3)
( 1515 - 1545 )
Tea break at Exhibition Area
(Concourse, Level 3)
( 1500 - 1535 )
Symposium 3 ( 1545 - 1725 )
Prevention
Chairpersons: Dr Mary PETROU, United Kingdom /
Dr THONG Meow Keong, Malaysia
* Screening and Ethics of Prevention
Dr Mary PETROU, United Kingdom
* Thalassaemia Screening Programmes: The
Malaysian Experience
Dr THONG Meow Keong, Malaysia
* Non-Invasive Prenatal Diagnosis
Prof Rossa CHIU, Hong Kong SAR
* Pre-implantation Genetic Diagnosis
Prof Anver KULIEV, United States of America
* Pre-implantation Genetic Diagnosis: The Singapore Experience
A/Prof Samuel CHONG, Singapore
Session 3 ( 1530 ?1700 )
Chairpersons: Dr Paul TELFER, United Kingdom /
Ms LEOW Siew Tin, Singapore
* Growth & Development - Puberty
Dr Nikos SKORDIS, Cyprus
* Endocrinology
Dr Vera OH, Singapore
* Bones, Osteoporosis
Dr Ersi Dimoula VOSKARIDOU, Greece
* Diet
Ms Christine ONG, Singapore
Q & A
Free Papers 3
( 1530 - 1710 )
Novartis Dinner Symposium
(For Medical Professionals only)
( 1830 - 2100 )
TOP>
Main Programme, Day 2, 9 October 2008 (Thursday)
Suntec Singapore International Convention & Exhibition Centre
Room 1 Room 2
11th International Conference on
Thalassaemia & Haemoglobinopathies 13th International TIF Conference for Thalassaemia Patients & Parents
Plenary 2 ( 0800 - 0835 )
Survival Trends in Thalassaemia Major
Dr Caterina BORGNA-PIGNATTI, Italy
Symposium 4 ( 0835 - 1000 )
Infections in Thalassaemia
Chairperson: Dr TAN Ban Hock, Singapore / Dr KOH Pei Lin, Singapore
* Immune Status of Chronically Transfused Patients
Dr LI Chi Kong, Hong Kong SAR
* Overview of Infections in Thalassaemia
Prof Galia RAHAV, Israel
* Management of Asplenic Patients
Dr TAN Ban Hock, Singapore
Parents/Patients Interactive Session
( 0830 - 1000 )
Tea break at Exhibition Area (Concourse, Level 3) ( 1000 - 1020 )
Symposium 5 ( 1020 - 1150 )
Cardiac Complications
Chairperson/s:Dr TAN Ru San, Singapore/
Dr Athanasios AESSOPOS, Greece
* The Heart in Transfusion Dependent Thalassaemia
Dr Athanasios AESSOPOS, Greece
* The Role of MRI T2*
Dr Dudley PENNELL, United Kingdom
* Treatment of Heart Failure in Thalassaemia Major
Dr John WOOD, United States of Amercia
Parents/Patients Interactive Session
( 1020 - 1150 )
Lunch Break
( 1150 - 1305 )
Osato Lunch Symposium (By Invitation)
( 1150 - 1320 )
Lunch Break
( 1150 - 1305 )
Launch of TIF New Guidelines Book
(1320 - 1340)
Dr Androulla ELEFTHERIOU, Cyprus
Plenary 3 ( 1340 - 1420 )
New Insights in Iron Chelation
Prof Antonio PIGA, Italy
Symposium 6 ( 1420 - 1540 )
Iron Chelation 1
Chairpersons: Dr Dudley PENNELL, United Kingdom /
Prof John PORTER, United Kingdom
* Pathophysiology of Iron Overload
Dr Z Ioav CABANTCHIK, Israel
* Iron Overload: Consequences
Prof John PORTER, United Kingdom
* Iron Chelation: Overview and Monitoring
Prof Maria Domenica CAPPELLINI, Italy
* Iron Chelation: Impact on Survival
Dr Paul TELFER, United Kingdom
Tea break at Exhibition Area (Concourse, Level 3)
( 1540 - 1610 )
Symposium 7
( 1610 - 1740 )
Iron Chelation 2
Chairpersons: Prof Aurelio MAGGIO, Italy / Prof Maria Domenica CAPPELLINI, Italy
* Future Developments in Oral Iron Chelators
Dr Des R RICHARDSON
* Is There an Optimal Strategy for Iron Chelation?
Prof Renzo GALANELLO, Italy
* Management of the 'Difficult'Iron Overloaded Patient
Prof Aurelio MAGGIO, Italy
Conference Dinner (By Ticket ONLY)
( 2000 - 2230 )
TOP>
Main Programme, Day 3, 10 October 2008 (Friday)
Suntec Singapore International Convention & Exhibition Centre
Room 1
Room 2
Room 3
11th International Conference on Thalassaemia & Haemoglobinopathies 13th International TIF Conference for
Thalassaemia Patients & Parents
Plenary 4 ( 0800 - 0835 )
Fertility and Pregnancy in Thalassaemia Major
Dr Susan M TUCK, United Kingdom
Session 4 ( 0800 - 0930 )
Chairpersons: Prof Antonio PIGA, Italy/ Mr George CONSTANTINOU, United Kingdom
* HbE & Thalassaemia Intermediate
Dr Vip VIPRAKASIT, Thailand
Chelation
* Different Types of Chelators
Prof Alan COHEN, United States of America
* Iron Chelation Treatment Under Economic Restrictions
Dr Suthat FUCHAROEN, Thailand
* Iron Overload and Consequences
Dr GOH Ai Sim, Malaysia
Q & A
Symposium 8 ( 0835 - 1020 )
Endocrine Complications
Chairperson/s: Dr Ratna CHATTERJEE, United Kingdom /
Dr Rekha BAJORIA, United Kingdom
* New Perspectives on Hormone Replacement Therapy in Thalassaemia
Dr Ratna CHATTERJEE, United Kingdom
* Growth and Thalassaemia
Dr Fabian YAP, Singapore
* Current Perspectives on Pregnancies in Thalassaemia Major
Dr Rekha BAJORIA, United Kingdom
* The Burden of Osteoporosis in Thalassaemia
Dr Ersi Dimoula VOSKARIDOU, Greece
* The Impact of Genotype on Endocrine Complications
Dr Nikos SKORDIS, Cyprus
Tea break at Exhibition Area (Concourse, Level 3)
( 1020 - 1040 )
Symposium 9 (1040 - 1210)
Liver Disease in Thalassaemia
Chairpersons: Dr LEE Lai Heng, Singapore / Prof Ali TAHER, Lebanon
* Overview of Liver Disease in Thalassaemia
Dr James O'BEIRNE, United Kingdom
* Update on Management and Prevention of Hepatitis B
A/Prof CHOW Wan Cheng, Singapore
* Hepatitis C in Thalassaemia Patients
Dr Roland CHONG, Singapore
Session 5 ( 1000 - 1130 )
Chairpersons:
Tan Ee Shien, Singapore / Mr Michael MICHAEL, United Kingdom
Psychosocial Problems
* Patient's Perspectives
Ms Louisa Di PIETRO, Australia
* Parent's Perspectives
Mrs Nailya T GULIYEVA, Azerbaijian
Hospital & Doctor Relationships
* Doctors' Relationship and Responsibilities
Prof Amal EL-BESHLAWY, Egypt
* Hospital’s Relationship and Responsibilities
To be confirm
Q & A
Lunch Break
( 1210 - 1310)
Lunch Break
( 1130 - 1300)
Plenary 5 (1310 - 1345)
Emerging Infections in Blood Transfusions
Dr Roger Y DODD, United States of America Session 6 ( 1300 - 1430 )
Chairpersons: Dr GOH Ai Sim, Malaysia/
Mr Riyad ELBARD, Canada
Symposium 10 ( 1345 - 1525 )
Blood Transfusion
Chairpersons: Dr Diana TEO, Singapore/
Prof Constantina POLITIS, Greece
* Blood Safety in the Asia Pacific Region
Dr Diana TEO, Singapore
* Haemovigilance and Transfusion Safety
Dr Peter FLANAGAN, New Zealand
* Advances in Blood Transfusion Therapy
Prof Alan COHEN, United States of America
* Red Blood Cell Pathogen Inactivation
Prof Constantina POLITIS, Greece
Liver & Its Problems
* How / Why Liver Has Its Problems? What are the Problems? How
to Detect (Signs and Symptoms)?
Dr LI Chi Kong, Hong Kong SAR, China
* Future Treatments for Liver Problems / Failure
Dr James O'BEIRNE, United Kingdom
Iron Measurement - MRI & Its Roles
* T2*
Dr TAN Ru-San, Singapore
* Ferriscan
Dr Farrukh SHAH, United Kingdom
Q & A
Tea break at Exhibition Area (Concourse, Level 3)
( 1525 - 1545 )
Tea break at Exhibition Area (Concourse, Level 3) ( 1430 - 1500 )
Symposium 11 (1545 - 1715)
Thalassaemia Intermedia / HbE
Chairpersons: Prof Eliezer RACHMILEWITZ, Israel /
Dr Anselm LEE, Singapore
* Thromboembolic Complications in Thalassaemia Intermedia
Prof Ali TAHER, Lebanon
* Cardiac Function and Abnormalities in Thalassaemia Intermedia
Dr Athanasios AESSOPOS, Greece
* Haemoglobin E-b-Thalassaemia
Dr Suthat FUCHAROEN, Thailand
Session 7 (1500 - 1610)
Chairpersons: Dr Michael ANGASTINIOTIS, Cyprus /
Mrs Nailya T GULIYEVA, Azerbaijan
* Government Relationships & Responsibilities
Ms Dawn ADLER, United States of America
* Nurses' Relationships & Responsibilities
S/r Emma PRESCOTT, United Kingdom
* Nurses' Relationships & Responsibilities, The Asian Experience
S/r OOI Ee Ee, Malaysia
Q & A
Asian Network of Collaboration
( 1800 - 2200 )
TOP>
Main Programme, Day 4, 11 October 2008 (Saturday)
Suntec Singapore International Convention & Exhibition Centre
Room 1
Room 2
Room 4
11th International Conference on Thalassaemia & Haemoglobinopathies 13th International TIF Conference for
Thalassaemia Patients & Parents
Plenary 6 ( 0800 - 0835 )
The Future of Stem Cell Transplant in Thalassaemia
Prof Guido LUCARELLI, Italy
Symposium 12 ( 0835 - 1000 )
Haematopoietic Stem Cell Transplantation
Chairpersons: Prof Guido LUCARELLI, Italy /
Dr William HWANG, Singapore
* Stem Cell Transplant for Thalassaemia - Who Should Have It?
Prof Guido LUCARELLI, Italy
* Stem Cell Transplant for Thalassaemia - Experience in a Developing Country
Prof LIN Hai Peng, Malaysia
* Cord Blood Banking and Transplant in Thalassaemia
Dr William HWANG, Singapore
Tea break at Exhibition Area (Concourse, Level 3)
( 1000 - 1020 )
Symposium 13 ( 1020 - 1200 )
Psychosocial Care
Chairpersons: Dr Michael ANGASTINIOTIS, Cyprus /
Dr CHAN Mei Yoke, Singapore
* Improving the Quality of Life in Thalassaemia
Prof Antonio PIGA, Italy
* The Adolescent Thalassaemic
Dr Michael ANGASTINIOTIS, Cyprus
* Strategies to Ensure Compliance to Treatment in Thalassaemia
Dr Caterina BORGNA-PIGNATTI, Italy
* Patients' Perspective
Mr George CONSTANTINOU, United Kingdom
2nd Ithanet Scientific Workshop
(1030 - 1250)
Lunch Break
( 1200 - 1315)
Lunch Break
(1250 - 1400)
Symposium 14 ( 1315 - 1455 )
Organisation of Thalassaemia Services
Chairperson/s: Prof Alan COHEN, United States of America /
Prof Antonio PIGA, Italy
* Organisation of Thalassaemia Services: The Sardinian
Experience
Prof Renzo GALANELLO, Italy
* Thalassaemia Services in Asia: The Asian Thalassaemia
Network
Dr Suthat FUCHAROEN, Thailand
* The Role of TIF and Patient Associations in Promoting the
Quality of Thalassaemia Services
Mr Panos ENGLEZOS, Cyprus
* Patients' Rights
Dr Androulla ELEFTHERIOU, Cyprus
* Introduction to M.Sc Course in Haemoglobinopathies
Dr Rekha BAJORIA, United Kingdom
2nd Ithanet Scientific Workshop
(1400 - 1500)
Tea break at Exhibition Area (Concourse, Level 3)
( 1455 - 1515 )
Symposium 15 ( 1515 - 1600 )
Alpha Thalassaemia
Chairperson/s: Dr LAW Hai Yang, Singapore /
Prof Swee Lay THEIN, United Kingdom
* HbH Disease: A Wide Spectrum of Clinical Severity
Dr Vip VIPRAKASIT, Thailand
* Spectrum of Alpha Thalassaemia Mutations in SE Asia
Dr LAW Hai Yang, Singapore
* Understanding Alpha-globin Gene Regulation
Dr Richard GIBBONS, United Kingdom
Parents' Interactive Session
(1515 - 1630)
Symposium 16 ( 1600 - 1700 )
Sickle Cell Disease
Chairperson/s: Dr Anselm LEE, Singapore /
Dr Mark WALTERS, United States of America
* Pathophysiology of Sickle Cell Disease
Dr Paul TELFER, United Kingdom
* Prevention of Complications in Sickle Cell Disease
Dr Bernard DAVIS, United Kingdom
* Stem Cell Transplantation for Sickle Cell Anaemia: Why, When
and How?
Dr Mark WALTERS, United States of America
National Association Interactive Sessions ?
Developed Countries & Developing Countries
( 1630 - 1730 )
TOP>
A Novartis-Sponsored Satellite Lunch Symposium,
8 October 2008 (Wednesday)
The Role of Bisphosphonates in Increasing Bone Mineral Density in Patients with Thalassaemia-Induced
Osteoporosis
1230 - 1235 Welcome and Introduction Ersi Voskaridou
1235 - 1255 Osteoporosis in Thalassaemia Patients
* Prevalence of osteoporosis in patients with thalassaemia and contributing factors (eg, hypogonadism,
bone marrow expansion)
* Dysregulation of bone metabolism – activation of bone resorption in patients with thalassaemia
* Zoledronic acid for treatment of thalassaemia
-induced osteoporosis – dosing regimens and results
Ersi Voskaridou
1255 - 1315 The Role of Bone Markers in Thalassaemia – A Haematologic Perspective
* Bone markers as measures of ongoing bone metabolism and response to therapy
* Zoledronic acid in patients with thalassaemia
– effect on bone markers and correlation with improved skeletal health
Evangelos Terpos
1315 - 1325 Questions and Answers Ersi Voskaridou
Evangelos Terpos
1325 - 1330 Concluding Remarks and Adjournment Ersi Voskaridou
TOP>
A Novartis-Sponsored Satellite Dinner Symposium,
8 October 2008 (Wednesday)
Optimizing Iron Chelation Therapy:
Bridging Clinical Data and Patient Management
1830 – 1930 Dinner
1930 – 1935 Welcome and introduction John Porter (London, UK)
1935 – 2000 Complete iron chelation: progressing insights
Content
* Iron overload and organ damage
* Cardiac iron loading due to transfusional iron overload
* NTBI and control with deferasirox
* Removal of cardiac and hepatic iron with deferasirox
John Porter (London, UK)
2000 – 2025 Iron chelation therapy; what have we learned recently?
Content
* Beneficial effects of iron chelation therapy
* Short overview currently available iron chelators
* TIF guidelines: iron chelation algorithm
* Deferasirox
- 3.5 year clinical trial data on efficacy and safety
- new data on doses > 30 mg/kg/day
* Effect of deferasirox on quality of life
Maria Domenica Cappellini (Milan, Italy)
2025 – 2050 How to optimally manage iron toxicity in our daily practice
Content
* Case study of a patient with thalassaemia major who is treated effectively with deferasirox (dose > 30
mg/kg/day). The case presentation will focus on:
- Tcorrect dosing (starting dose and titration) of deferasirox
- adverse event management
Ali Taher (Beirut, Lebanon)
2050 – 2100 Panel discussion
TOP>
Osato Research Institute Lunch Symposium, 9 October 2008 (Thursday)
Protection of Oxidative Stress in Hemoglobinopathies and in DNA damaged liver cells by Fermented Papaya
Preparation (FPP)
Osato Research Institute is proud to host a Sponsored Lunch Symposium
on October 9th , 2008 at the International Thalassemia Conference
This free Lunch Symposium is being presented at
Ballroom 2 from 11H50 to 13H05
and its goal is to share with the medical professionals the clinical trials on:
Protection of Oxidative Stress in Hemoglobinopathies and in DNA damaged liver cells by Fermented Papaya
Preparation (FPP)
Introduction
Eliezer Rachmilewitz , MD
Edith Wolfson Medical Center, Holon-Israel
Speakers
What is Oxidative Stress?
Andrew Jenner, Ph.D.
National University of Singapore
The Effect of Fermented Papaya Preparation ( FPP ) on oxidative stress in hemoglobinopathies
Eitan Fibach, Ph.D.
( Hadassah University Hospital, Ein-Kerem, Jerusalem, Israel )
DNA Protection in the liver by FPP,
Evidence from clinical trials
Francisco Marotta , Ph.D.
University of Milano , Italy
Keep in mind that seating is limited to 500, so please come early to reserve your seat at the Lunch
Symposium. We hope to see you there.
We encourage you to visit Osato International exhibiting booth # 6 during the conference to learn more about
our product and the numerous independent scientific publications.
TOP>
* Programme subject to change without prior notice.
Organised by: Supported by
Conference Secretariat &
Housing Bureau:
Home | Contact Us | Website by ace:daytons direct | © 2007 International Thalassaemia Conference 2008
ITC 2008 Conference website updated as of 08/28/2008
§ãJ¡Ð ساجد:
Wow! quite a few things going around!
Sharmin:
I am looking forward to hearing how they address these items.
I hope Micheal Antoniou has something exciting to say:)
Sharmin
nice friend:
hey ...
why dont you try to shooot all conference .. and then upload on youtube ... then it willl available for all members . and all over the world for internet users..
poo gill:
Hi Andy
I was going thru the agenda and there are some interesting topics running parallely, how should we divide ourselves so that none of the topics get missed up.
Also is there a way it will be available for other members. Have you spoken to Kymn, or shal I talk to her.
Thanks
Puja
Navigation
[0] Message Index
[#] Next page
Go to full version